Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
2.090
+0.100 (5.03%)
At close: Aug 27, 2025, 4:00 PM
2.050
-0.040 (-1.91%)
After-hours: Aug 27, 2025, 7:45 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $163.79 million as of August 27, 2025. Its market cap has decreased by -34.35% in one year.
Market Cap
163.79M
Enterprise Value
159.76M
1-Year Change
-34.35%
Ranking
Category
Stock Price
2.09
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $163.79M, an increase of 81.56%. That is a compound annual growth rate of 24.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 155.96M | 89.53% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |